Business

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

Veteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience,

articleLifeward Ltd.May 19, 20263/company/rewalk-robotics-ltd/news/lifeward-appoints-dr-keith-d-rose-as-chief-medical-officer-to-support-expansion-of-neurorehabilitation-portfolio-and-advance-biomed-platform
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

About this update from Lifeward Ltd.

[{"type":"text","content":"Veteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience, mobility technologies, and metabolic disease Promotion reflects Lifeward’s continued investment in clinical innovation, evidence generation, and patient outcomes across its expanding med-tech rehabilitation and biomed technology portfolio HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced the appointment of Keith D. Rose, M.D., as Chief Medical Officer. Dr. Rose, who previously served as Vice President, Medical Affairs and Medical Director, Neurosciences at Lifeward, will lead the Company’s global medical strategy. “Keith has already made a significant impact at Lifeward through his clinical leadership, scientific expertise, strategic insight, and deep commitment to patients,” said Mark Grant, CEO of Lifeward. “As we continue to broaden our rehabilitation technology portfolio and advance our newly acquired biomedical assets, Keith’s extensive background in physical medicine, neuroscience, metabolic disease, and medical affairs makes him exceptionally well-positioned to help drive our next phase of growth.” Dr. Rose brings more than three decades of experience in rehabilitation medicine, neuroscience, medical affairs and patient care across both clinical practice and the medical technology and biopharmaceutical industries. Since joining Lifeward in 2023, he has played a key role in advancing the Company’s medical affairs strategy, supporting payer engagement initiatives, strengthening relationships with clinicians and key opinion leaders, and expanding scientific and clinical education efforts across the organization. “I am honored to step into the role of Chief Medical Officer at such an exciting time for Lifeward,” said Dr. Rose. “Lifeward is uniquely positioned at the intersection of innovation, rehabilitation and patient empowerment. I look forward to continuing to work alongside our talented team to expand access to life-changing technologies and therapies that help improve outcomes.” Prior to joining Lifeward, Dr. Rose held senior medical affa...

More updates from Lifeward Ltd.